BMS-929075 Uses, Dosage, Side Effects and more
BMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).
| Trade Name | BMS-929075 |
| Generic | BMS-929075 |
| Type | |
| Formula | C31H24F2N4O3 |
| Weight | Average: 538.555 Monoisotopic: 538.181646975 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
